Lumoptik Inc.
Providing prolonged drug delivery inside the eye
This article was originally published in Start Up
Executive Summary
VEGF inhibitors have revolutionized the treatment of age-related macular degeneration, but there’s no getting around the need for lifelong, monthly injections straight into the eye. Lumoptik Inc. has developed a precision navigation system that may allow for more effective, prolonged drug delivery, resulting in less frequent injections over the same time period.